Allen D.R. and Browse N.L. (1990). The effect of cigarette smoke, nicotine and carbon monoxide on arterial wall uptake of 125I fibrinogen. Adv Exp Med Biol;273, 95-106
2.
Bakker W.W., Poelstra K., Barradas M.A. and Mikhailidis D.P. (1994). Platelets and ectonucleotidases . Platelet;5, 121-129
3.
Bartecchi C.E., Mackenzie T.D. and Schrier R.W. (1994). The human cost of tobacco use. N Engl J Med;330, 907-912
4.
Bath P M W, Hassell D.G., Gladwin A.M. et al (1991). Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium, in vitro. Arteriosclerosis Thromb;11, 254-260
5.
Bondjers G., Hansson G., Olsson G. and Pettersson K. (1990). Smoking, catecholamines and their effects on endothelial cell integrity. Adv Exp Med Biol;273, 51-59
6.
Bull H.A., Pittilo R.M., Blow D.J. et al (1985). The effects of nicotine on PGI2 production by rat aortic endothelium, Thromb Haemost;54, 472-474
7.
Bull H.A., Pittilo R.M., Woolf N. and Machin S.J. (1988). The effect of nicotine on human endothelial cell release of prostaglandins and ultrastructure. Br J Exp Pathol;69, 413-421
8.
Caldwell P R B, Segal B.C., Hsu K.C., Das M. and Soffer R.L. (1976). Angiotensin converting enzyme: vascular endothelial localisation. Science ;191, 1050-1051
9.
Church D.F. and Pryor W.A. (1985). Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect;64, 111-126
10.
Crawford N. and Scrutton M.C. (1987). Biochemistry of the blood platelet. In: Bloom A L, Thomas D P (eds). Hemostasis and Thrombosis, 47-77. Edinburgh: Churchill Livingstone
11.
Eckel R.H. (1989). Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med;16, 1060-1068
Friedman G.D., Klatsky A.L. and Siegelaub A.B. (1974). The leukocyte count as a predictor of myocardial infarction. N Engl J Med; 290, 1275
14.
Furchgott R.F. (1983). Role of endothelium in responses of vascular smooth muscle. Circ Res;53, 557-573
15.
Gerrity R.G. (1981). The role of monocytes in atherosclerosis. I. Transition of blood borne monocytes into foam cells in fatty lesions. Am J Pathol;103, 181-185
16.
Harats D., Ben-Naim M., Dabach Y. et al (1989). Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis;79, 245-255
17.
Harats D., Ben-Naim M., Dabach Y. et al (1990). Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis;85, 47-54
18.
Henning B. and Chow C.K. (1988). Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad Biol Med;4, 99-106
19.
Higman D.J., Greenhalgh R.M. and Powell J.T. (1993). Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg;80, 1242-1246
20.
Hoshino E., Shariff R., Van Gossum A. et al (1990). Vitamin E suppresses increased lipid peroxidation in cigarette smokers. J Parenter Enteral Nutr;14, 300-305
21.
Jeremy J.Y. (1994). Smoking and vascular defence mechanisms. J Smoking-Rel Disord; 5 (Suppl 1), 49-54
22.
Jeremy J.Y. and Mikhailidis D.P. (1990a). Vascular and platelet eicosanoids, smoking and atherosclerosis. Adv Exp Med Biol;273, 135-146
23.
Jeremy J.Y. and Mikhaildis D.P. (1990b). Smoking and vascular prostanoids: relevance to the pathogenesis of atheroma and thrombosis. J Smoking-Rel Disord; 1, 59-69
24.
Jeremy J.Y. and Mikhailidis D.P. (1990c). Prostaglandins and the penis: possible role in impotence. Sex Mar Ther; 5, 155-165
25.
Jeremy J.Y., Mikhailidis D.P. and Dandona P. (1988). Excitatory receptor-linked prostanoid synthesis in mammalian smooth muscle: the role of calcium, protein kinase C and G proteins . Prostaglandins, Leukotrienes, Essential Fatty Acids;34, 215-228
26.
Jeremy J.Y., Mikhailidis D.P. and Dandona P. (1985). Cigarette smoke extracts but not nicotine inhibit vascular prostacyclin synthesis. Prostaglandins Leukotrienes Med;19, 261-270
27.
Kalra J., Chaudhary A.K. and Prasad K. (1991). Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol;72, 1-7
28.
Karino T. and Goldsmith H.L. ( 1987). Rheological factors in thrombosis and haemostasis . In: Bloom A L, Thomas D P (eds). Haemostasis and Thrombosis, 739-755. Edinburgh : Churchill Livingstone
29.
Kershbaum A., Khorsandian RF, Caplan S. et al (1983). The role of catecholamines in the free fatty acid response to cigarette smoking. Circulation; 28, 52-60Krauss R M. (1991). The tangled web of coronary risk factors. Am J Med; 90 (suppl 2A), 36S-41S
30.
Kutti J. (1990). Smoking, platelet reactivity and fibrinogen. Adv Exp Med Biol;273, 129-134
31.
Libby P., Warner S J C and Friedman G.B. (1988). Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostaglandins . J Clin Invest;81, 487-493
32.
McGill H.C. Jr (1977). Atherosclerosis: problems in pathogenesis. Atherosclerosis Rev; 2, 27-65
33.
Meade T.W. (1993). Cardiovascular disease. Risk factors and intervention . In: Poulter N, Sever P and Thom S, (eds) 185-195Oxford : Radcliffe Medical Press
34.
Mikhailidis D.P., Barradas M.A., Jeremy J.Y., Gracey L., Wakeling A. and Dandona P. (1985). Heparin-induced platelet aggregation in anorexia nervosa and in peripheral vascular disease. Eur J Clin Invest;15, 313-319
35.
Mikhailidis D.P. and Jeremy J.Y. (1993). Smoking and erectile impotence. Int Angiol;12, 297-298
36.
Molgaard J. and Olsson A.G. (1990). Apolipoprotein profiles in randomly selected smokers and matched controls. Adv Exp Med Biol;273, 259-266
37.
Moncada S. and Vane J.R. (1979). Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Revs;30, 293-331
38.
Murray J.J., Nowak J., Oates J.A. and Fitzgerald G.A. (1990). Platelet-vessel wall interactions in individuals who smoke cigarettes. Adv Exp Med Biol;273, 189-198
39.
Naito M., Hayashi T., Kuzuya M. et al (1990). Effect of fibrinogen and fibrin on the migration of vascular smooth muscle cells, in vitro. Atherosclerosis;83, 9-14
40.
Noronha-Dutra A.A., Epperlein M.M. and Woolf N. (1993). Effect of cigarette smoking on cultured human endothelial cells. Cardiovasc Res;27, 774-778
41.
Nyström M.L., Barradas M.A. and Mikhailidis D.P. (1993). N-formylmethionineleucine-phenylalanine (fMLP), a bacterial chemotactic peptide, stimulates platelet shape change in human whole blood. Platelets ;4, 156-158
42.
Palmer R M J, Ferrige A.G. and Moncada S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature;327, 524-527
43.
Petty R.G. and Pearson J.D. (1989). Endothelium: the axis of vascular health and disease . J Roy Coll Phys;23, 92-100
44.
Pittilo R.M. (1990). Cigarette smoking and endothelial injury: a review . Adv Exp Med Biol;273,61-78
45.
Pittilo R.M., Mackie I.J., Rowles P.M., Machin S.J. and Woolf N. (1982). Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb Haemost;48, 173-176
46.
Pittilo R.M. and Woolf N. (1993). Cigarette Smoking, Endothelial Cell Injury and Atherosclerosis. J Smoking-Rel Disord;4, 17-25
47.
Pomerantz K.B. and Hajjar D.P. (1989). Eicosanoids in regulation of arterial smooth muscle phenotype, proliferative capacity and cholesterol metabolism. Arteriosclerosis;9, 413-422
48.
Ross R. ( 1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature;362, 801-806
49.
Shukla N., Jeremy J.Y., Nicholl P. et al (1994). Nicotine stimulates [3H] -thymidine incorporation into cultured human vascular smooth muscle cells. J Smoking-Rel Disord; 5 (Suppl 1), 327
50.
Sixma J.J. (1987). Role of blood platelets, plasma proteins and the vessel wall in hemostasis. In: Bloom A L, Thomas D P (eds). Haemostasis and Thrombosis , 283-302. Edinburgh: Churchill Livingstone
51.
Taubman M.B., Berk B.C., Izumo S. et al (1989). Angiotensin II induces c-fos mRNA in aortic smooth muscle. J Biol Chem;264, 526-530
52.
Thomas P.S., Schrek R.E. and Lazaruas S.C. (1992). Tobacco smoke releases preformed mediators from canine mast cells and modulates prostaglandin production. Am J Physiol; 263,L97-L72
53.
Van Antwerpen V.L., Theron A.J., Richards G.A. and Anderson R. (1994). Plasma vitamin C in males. J Smoking-Rel Disord;5, 167-170
54.
Wagner D.D., Olmsted J.B. and Marder V.J. (1982). Immunolocalisation of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol;95, 355-359
55.
Warso M.A. and Lands W E M (1983), Lipoid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull;39, 277-281
56.
Wennmalm A. and Alster P. (1983). Nicotine inhibits vascular prostacyclin but not platelet thromboxane A2 synthesis. Gen pharmacol;14, 189-196
57.
Wiseman S., Powell J., Greenhalgh RM et al (1990). The influence of smoking and plasma factors on prosthetic graft patency. Eur J Varc Surg;4, 57-61
58.
Witzum J.L. and Steinberg D. (1991). Role of oxidised LDL in atherogenesis. J Clin Invest;88, 1785-1792
59.
Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsuf Y., Yazaki Y. and Masaki T. (1988). A novel potent vasconstrictor peptide produced by vascular endothelial cells. Nature;332, 411-415
60.
Yarnellj W.G., Baker I.A., Sweetman P.M. et al (1991). Fibrinogen viscosity and ischaemic white blood cell count are major risk factors for ischaemic heart disease. Circulation;83, 836-844
61.
Zimmerman M. and Mcgeachie J.K. (1990). The effects on nicotine and endothelial cell turnover and ultrastructure. Adv Exp Med Biol;273, 79-88